We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Allergan Litigates Over Eye Drop Patent

Law360 (May 10, 2007, 12:00 AM EDT) -- Allergan Inc. disclosed Wednesday that it has sued generic pharmaceutical company Exela PharmSci Inc. for allegedly infringing its patent for an eye drop medication used to treat glaucoma.

In a filing with the U.S. Securities and Exchange Commission, Allergan said it brought the lawsuit in March after learning Exela had filed an Abbreviated New Drug Application for a generic version of the glaucoma medication Aplhagan, otherwise known as 0.15% brimonidine tartrate ophthalmic solution.

Then, in April, Allergan filed an amended complaint with the U.S. District Court...
To view the full article, register now.